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Diagnosis and Treatment of ACTH-Producing Pitui tary Tumors 
O.A. Müller, X. Baur, R. Fahlbusch, M. Madler, F . Marguth, C. Uhlig, P.C. Scriba, 
Munich, and J.M. Bayer, Bonn, FRG 
I n t r o d u c t i o n 
In contrast to the almost clear-cut concept in treating growth hormone and prolactin 
producing pituitary tumors it seems to us more difficult to manage ACTH-producing 
pituitary tumors. One reason is certainly our rather limited experience due to the lack 
of cases with these ACTH-producing adenomas which are the least frequent endocrine 
active adenomas if one does not take into consideration rareties such as glycoprotein-
producing pituitary tumors. The other reason is most likely the resistance of the 
corticotrophic cell which is well established from the pathophysiology of pituitary 
diseases. The following study deals with our experience in treating patients with ACTH-
producing adenomas whom we have divided into two groups: Firstly patients with 
Cushing's disease with a pituitary tumor and secondly patients with Nelson's syndrome. 
Patients a n d M e t h o d s 
We studied 22 patients altogether, 7 with Cushing's disease and pituitary adenoma and 
15 with Nelson's syndrome. Details of the findings in our patients are summarized in 
Tables 1 and 2. Cortisol and thyroxin levels were measured by radioimmunoassay (RIA) 
or competitive protein-binding assay [1]. The ACTH levels were measured by RIA or by 
bioassay (in vitro corticosterone production by isolated adrenal cells according to 
Sayers et al. [2, 3]) both after ACTH extraction from plasma on silica-gel colums (un-
published). Synthetic human ACTH served as ACTH standard, kindly supplied by 
CIBA-GEIGY AG' Basel, Switzerland ( 1 - 3 9 - h - A C T H , CGP 2917). The preliminary 
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normal range for the plasma, ACTH level at 9 a.m. with these methods is between 20 
and 100pg/ml. TSH, hGH, hPRL and LH levels were measured by RIA with double-
antibody methods [4]. 
Results 
Pat ients w i t h Cushings's Disease and a P i t u i t a r y Tumor (n=7) 
The preoperative and postoperative findings are summarized in Table 1. Only 2 patients 
had considerable enlargement of the sella turcica whereas in the other 5 only a minor 
enlargement could be demonstrated by standard lateral skull x-ray or tomography. Only 
in 1 of the patients (S.W.) was there suprasellar extension of the pituitary tumor as 
demonstrated by visual field defects. Hypercortisolism was documented by elevated 
Table 1 Endocrine Evaluation, Operative Procedure and Tumor Histology in 7 Patients wi th 
Cushing's Disease and Pituitary Tumor 
n = normal 
t = elevated 
I = diminished 
— = no change (preoperative) 
or not present (postoperative) 
IHT = insulin-hypoglycemia-test 
ts = transsphenoidal 
tf = transfrontal 
cryo = cryohypophysectomy 
rad = radiation 
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basal serum Cortisol levels, hyperresponsiveness to exogenous ACTH, failure of sup-
pression or subnormal suppression by dexamethasone and abolition of the circadian 
rhythm. Typically for this disease, none of the patients showed a rise of Cortisol levels 
after adequate hypoglycemia and growth hormone secretion was blunted. ACTH de-
pendency of Cortisol secretion was documented by either an exaggerated rise of serum 
Cortisol levels after lysine-vasopressin or suppression of the urinary corticosteroid excre-
tion after large doses of dexamethasone or elevated ACTH levels. The other pituitary 
functions were not disturbed except in the two patients with the larger adenomas. 
In the 5 patients with only slight sellar enlargement a selective transsphenoidal adenom-
ectomy was performed. In the first two cases (E.R., H.M., Table 1) not only the clinical 
picture of Cushing's disease disappeared completely, but there was also total normaliza-
tion of the anterior pituitary function including the hypothalamo-pituitary-adrenal 
axis [5] . This was demonstrated by the postoperative Cortisol stimulation and suppres-
sion data in these patients: the basal serum Cortisol level was within the normal range 
and showed normal suppression after 2mg dexamethasone overnight and stimulation 
by intravenous ACTH. The endogenous ACTH level showed normal stimulation by 
insulin-induced hypoglycemia as reflected by a normal rise of the serum Cortisol level. 
The insulin dose necessary to achieve adequate hypoglycemia was half or less of the 
preoperative dose corresponding well to the disappearance of the diabetic carbohydrate 
metabolism in these patients. One patient (E.R.) showed a normal diurnal variation. 
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Although the other (H.M.) had an abnormal circadian rhythm, the disappearance of 
abnormal Cortisol secretion in this patient was documented by low normal urinary 
excretion of Cortisol metabolites and free Cortisol. The male patient who had preopera-
tively shown and exaggereated serum Cortisol response after lysine-vasopressin now 
had a normal rise of serum Cortisol during this test. In the next two patients (M.Ch., 
M.R.) a microadenoma was found during operation and confirmed by microscopic 
examination. In both cases hypercortisolism persisted postoperatively, whereas again 
the other pituitary functions remained intact. Despite these conflicting findings and 
with renewed postoperative increase of her ACTH level (Fig. 1) the female patient 
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ACTH 
ng/ml preop. introop.after turnor-exstirp. postop. 
4 
3 \ 2 
0.1 
0.01 
07 
0.5 
0.3 
0.2 M.Ch.os S. W. H. J. °" Fig. 1 Summary of the pre-, intra- and 
postoperative ACTH levels in four of the 
patients wi th Cushing's disease (Table 1) 
showed complete clinical remission of Cushing's disease with normalized mentrual 
bleedings. In the female patient H.J. the neurosurgeon already could not make out 
the adenoma with absolute certainty, nor could this diagnosis be confirmed by histologi-
cal examination. In keeping with these negative findings the clinical picture of the not 
very active Cushing's disease persis ted, in agreement with still elevated Cortisol and 
ACTH levels (Fig. 1). 
In two patients with the larger tumors (F.F. , S.W.) cryohypophysectomy was perform-
ed in addition to a transsphenoidal operation. One of these patients (F.F.) had shown 
extremely elevated ACTH levels comparable to those found in Nelson's syndrome 
(Fig. 1 ) . In both patients the clinical and laboratory findings of Cushing's disease were 
abolished and panhypopituitarism including diabetes insipidus were encountered. In 
one case (S.W.), in whom the microscopic examination had revealed signs of enhanced 
proliferation, Cushing's disease recurred one and a half years after the first operation 
accompanied by an invasively growing tumor. A second operation had to be performed 
on this patient by the transfrontal approach, followed by radiation therapy which has 
only just been completed (Table 1). For the time being the signs of Cushing's disease 
have regressed and a low normal basal Cortisol and ACTH level has been observed 
(Fig. 1 ) . The prognosis in this patient is uncertain. 
Our results have led us to believe that there are two different mechanisms leading to 
Cushing's disease. Some patients have a circumscribed autonomous pituitary adenoma 
[6 ,7 ] which can be selectively removed; this was demonstrated in two of our patients 
[5], one of whom has been in remission for more than five years after operation. The 
other mechanism seems to consist of a hypothalamic stimulus leading to pituitary 
corticotrophic hyperplasia with or withour adenoma formation [ 8 , 9 ] . For the latter 
type, our cases showing no remission postoperatively despite histologically proven 
adenomectomy may provide good evidence. 
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Patients with Nelson's Syndrome (n=15) 
In patients with Nelson's syndrome [10,11] the interpretations of clinical and laboratory 
findings are even more conflicting [12] . Our definition of this syndrome includes hyper-
pigmentation, markedly elevated ACTH levels and — most important — evidence of a 
pituitary tumor, as demonstrated by skull x-ray. 
Table 2 summarizes the preoperative clinical and laboratory data in 15 patients with 
Nelson's syndrome. They are subdivided into two groups: the first consists of patients 
not operated upon, the second contains the patients who received surgical treatment. 
In the patients of the first group there was a long period of latency between adrenal-
ectomy and sellar enlargement with the exception of one patient (M.T.). In all öf them 
the pituitary tumor was small and there was no evidence of anterior pituitary dys-
function and no progression of tumor growth for up to ten years. In the second group 
(n=9) the period between adrenalectomy and tumor development was in general shorter, 
in one patient (R.H.) a pituitary tumor was suspected already at the time of adrenal-
ectomy. The sella size increased during the follow-up period and in four cases (J.K., 
E.B., R.W., S.M.) the tumor grew out of the fossa turcica. In these 9 patients there was 
also evidence of anterior pituitary insufficiency, particularly in the patients with supra-
sellar extension of the tumor. The ACTH levels were always elevated and showed 
considerable variation without differing significantly in the two groups. This is also true 
for the ACTH levels after administration of dexamethasone, which are in general lower 
than the basal ACTH levels, and for the ACTH secretion stimulated by insulin-induced 
hypoglycemia (Fig. 2). Therefore no therapeutical consequences can be derived from 
the ACTH measurements alone. 
Table 3 summarizes operative procedures, tumor histology and postoperative endo-
crine evaluation of the nine patients operated upon. Four patients were operated upon 
by the transsphenoidal approach; the ACTH levels fell only slightly postoperatively. 
One patient (R.E.) was operated upon a second time ?fter which an initial fall of the 
ACTH level was observed, which, however, increased again during later follow-up 
investigations. One patient (A.La.) became pregnant postoperatively. One of these 
ng/ml 
20 
• bosol level. 9 A.M. 
I öfter 4«0.5mg/d dexamethasone over 2days 
i after 4«2.0mg/d 
| 45 min after insulin i.v. 
10 
i 2 
< 
3 1 
10.7 
.2 0.5 
Fig. 2 ACTH levels after various 
doses of dexamethasone and after 
insulin-hypoglycemia in patients 
with Nelson's syndrome (mean 
± SD). In patients marked wi th 
asterix bioassay was performed 
CQ 
0.3 
0.2 
0-v, 
0.01 M. f M.K? H.H. L.E. K.Sch. R.E* A.L* G.Sch.R.H* E.B.* ' 
1 never operated + operated - | 
NORMAL 
HANGE 
according to Lipscomb and Nelson 
(13, 14] 
Diagnosis and T r e a t m e n t o f A C T H - P r o d u c i n g P i t u i t a r y T u m o r s 3 4 9 
•-3 O 
0) (A 1 u 
u u u u u u 
P
o
st
o
p
e
ra
tiv
e 
fo
ll
ow
 
Up
 
1 °* 
1 ^ 
• 
• u 
1 * A
CT
H 
ff
 
(1
09
.0
5)
 
u — 
C <"si 
«0 • 
C t 
CT» — 
u 
a _ 
x P u 
<N < re
gr
es
si
on
 o
f 
op
ht
ha
lm
op
le
gi
a 
AC
TH
 
f 
(1
.7
8)
 
a
m
b
ly
o
p
ia
 l
e
ft
. 
he
m
ia
no
ps
ia
 r
ig
h
t 
+ 
7/
75
 
AC
TH
 f 
(1
.6
5)
 
Di
ab
et
es
 
in
si
pi
du
s 
i ' i i i 1 + + i i 1 i ' + i | + 
an
te
ri
or
 
pi
tu
it
ar
y 
fu
nc
ti
on
 
c c c c 
AC
TH
 
(n
g
/m
l)
 
CO 1 H 
r - i n 
•<r 1 co 
.H 
CO 
o> <N 
o 
T 
<N 
o 
Ü 
m 1 co I i n o • vx> 1 r -
O ' O | rH 
v ! 5 
Hi
st
ol
og
y 
ad
en
om
a 
ad
en
om
a 
ad
en
om
a 
ad
en
om
a 
ad
en
om
a 
au
en
om
a e o c o o 
(0 a
de
no
ma
 
ad
en
om
a 
ad
en
om
a 
ad
en
om
a 
ad
en
om
a 
wi
th
 s
ig
ns
 
of
 e
nh
an
-
ce
d 
pr
ol
i-
de
ra
ti
on
 
u
n
d
if
fe
re
n
t.
 
ad
en
om
a 
1 
Op
er
at
io
n 
ts
 
8/
71
 
ts
 
8/
72
 
ts
 
8/
71
 
ts
 
7/
71
 
ts
 
4/
72
 
ts
 
9/
74
 
+ 
cr
yo
 T r -
\ 0 
u o 
•J) *J + 
T 
\ • 
--< 'O u 
4J + ts
 
5/
72
 
+ 
cr
yo
 
tf
 
2/
73
 
+ 
ra
d.
 
tf
 1
2/
74
 
ts
 
8/
74
 
+ 
cr
yo
 
t f
 
2/
75
 
+ 
ra
d.
 
Ag
e 
(y
ea
rs
) 
ro —» o T o r o 
CO 
T 
i n 
X 
•/> 
O h o+ O f o+ 04- o+ 
CD 
E 
o 
•o 
c 
> co
"c 
o 
CD 
Z 
x: 
i 
nt
s 
c 
CD CO 
(Ö Q_ c 
o O) O 
c It 
CO o 
CD 
Q CD 
CD JD 
> CO H CD 
CD 
as CD a to 
o 
U) "5 
O X) 
Q_ E 
> 
CO > O 
m
a 
on
 
E '*-> CO 
CO c 
CO CO xp
l 
<D CD 
A v_ 
CO o H 
i-4 
patients (A.L.) documents the discrepancy between clinical improvement and ACTH 
level quite clearly (Fig. 3). Whereas after operation the cyclic ovarian function became 
normalized, the sella size remained unchanged and pituitary function returned to nor-
mal, there was constant increase of the basal ACTH level. 
Two patients (M.M., G.Sch., Table 3) were operated upon by the transsphenoidal route 
with additional cryohypophysectomy; postoperatively panhypopituitarism and diabetes 
insipidus were observed. Both patients showed depigmentation and their ACTH level 
decreased to low-normal values. The three patients with large tumors and ophthalmo-
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AMENORRHEA 
-regular menses-
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Fig. 3 ACTH levels and 
anterior pituitary funct ion 
pre- and postoperatively in 
a woman with Nelson's 
syndrome 
logical symptoms were operated upon by the transsphenoidal or transfrontal route in 
combination with radiotherapy and/or cryohypophysectomy. The second operations 
were necessitated by progressing tumor growth, increasing ACTH levels and deteriora-
tion of vision. Complete panhypopituitarism had to be encountered. Two patients are 
now on remission whereas one patient died half a year after the third operation due to 
invasive growth of his pituitary tumor. 
Conclusions 
The data we have accumulated suggest that patients with Cushing's disease and pitui-
tary tumors and patients with Nelson's syndrome have the same underlying disease 
appearing in various modifications. They have the following in common: 
1. Occurrence of 
— either small adenomas with a minimal growth potential 
— or large, potentially invasive tumors. 
2 . Extremely high ACTH levels, occasionally occurring also in Cushing's disease. 
3. Histological and electronmicroscopic appearance of the adenomas [ 5 , 1 5 ] . 
4. Probably either autonomous adenoma of the pituitary or hypothalamic CRF-excess 
as primary cause. 
However, Cushing's disease with pituitary adenoma and Nelson's syndrome differ in 
respect of therapy requirements. In the patients with Cushing's disease neurosurgical 
treatment should cure the hypercortisolism and the tumor, whereas in cases with 
Nelson's syndrome the indication for surgical treatment depends upon tumor size 
and the rapidity of growth. 
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